BRG1 promoted the expression of STAT3‐regulated genes involved in immune evasion and metabolic reprogramming in GBM, and BRG1 suppressed the expression of tumour suppressor genes and genes involved in immune surveillance in GBM. The gene discussed is SMARCA4; the disease is glioblastoma.